| abstract |
The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG1] a: FIG.1A 9000. o 5mg/mL Nanosuspension o 8000- o 4x25mg tablets E 7000- A 100mg tablet 6000.: c_ 5000 o 3000 80 48 1216 20 24 28 32 36 40 44 48 Time(h) E 100000o 5mg/mL Nanosuspension o 4x25mg tablets A 100mg tablet u 1000. co ou 10 d 0 4 8 12 16 20 24 28 32 36 40444 Time (h) |